(Q37970434)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2218829%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

review article

1 reference

title

Prognostic indicators in invasive breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2218829%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

author name string

M C Sunderland

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2218829%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

W L McGuire

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2218829%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

publication date

1 October 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2218829%20AND%20SRC:MED&resulttype=core&format=json

Surgical Clinics of North America

25 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2218829%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2218829%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2218829%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

page(s)

989-1004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2218829%20AND%20SRC:MED&resulttype=core&format=json

DNA flow cytometry in the prognosis of node-negative breast cancer

25 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Steroid receptors, cellular kinetics, and lymph node status as prognostic factors in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

The molecular genetics of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

In Vivo Amplification and Rearrangement of c-myc Oncogene in Human Breast Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Genetic alterations in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

DNA aneuploidy and cell proliferation in breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Progesterone receptors as a prognostic factor in Stage II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

DNA ploidy and survival in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

DNA index and cell cycle analysis of primary breast cancer and synchronous axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Observations on survival curve analysis with particular reference to breast cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Cytometric characterization and clinical course of breast cancer diagnosed in a population-based screening program

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Node-negative breast cancer treated by modified radical mastectomy without adjuvant therapies: variables associated with disease recurrence and survivorship

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: A proposed classification of DNA histograms in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Tumour DNA ploidy as an independent prognostic factor in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Tamoxifen in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

High Frequency of Rare Alleles of the Human c-Ha-ras-1 Proto-oncogene in Breast Cancer Patients2

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

The value of estrogen and progesterone receptors in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Tumour aneuploidy, prognostic parameters and survival in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Progesterone receptor activity and relapse-free survival in patients with primary breast cancer: the role of adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Oncogenes as clinical prognostic indicators

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

The long-term prognostic significance of the thymidine labelling index in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945226-6

7 January 2021

10.1016/S0039-6109(16)45226-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2218829%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

1 reference